Effect of coumarins started before coronary angioplasty on acute complications and long-term follow-up: A randomized trial

Circulation

Volumn 102, Issue 4, 2000, Pages 386-391

  Ten Berg, Jurriën M ^a   Kelder, Johannes C ^b   Suttorp, Maarten Jan ^b   Mast, E Gijs ^b   Bal, Egbert ^b   Ernst, Sjef M P G ^b   Verheugt, Freek W A ^a   Plokker, H W Thijs ^b  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b NONE

Author keywords

Angioplasty; Anticoagulants; Warfarin sodium

Indexed keywords

ACETYLSALICYLIC ACID; COUMARIN; HEPARIN; TICLOPIDINE;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DRUG EFFECT; FALSE ANEURYSM; FEMALE; FOLLOW UP; HUMAN; INTERNATIONAL STANDARD UNIT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; RISK BENEFIT ANALYSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0034713817     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.cir.102.4.386     Document Type: Article

References (21)

1. de Feyter PJ, van den Brand M, Laarman GJ, et al. Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty: frequency, prediction, clinical course, management, and follow-up. Circulation. 1991;83:927-936.
2. Serruys PW, Luijten HE, Beatt KJ, et al. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon: a quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation. 1988;77:361-371.
3. Kohchi K, Takebayashi S, Block PC, et al. Arterial changes after percutaneous transluminal coronary angioplasty: results at autopsy. J Am Coll Cardiol. 1987;10:592-599.
4. White CJ, Ramee SR, Collins TJ, et al. Coronary angioscopy of abrupt occlusion after angioplasty. J Am Coll Cardiol. 1995;25:1681-1684.
5. Harker LA. Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty. Am J Cardiol. 1987;60:20B-28B.
6. Schwartz RS, Holmes DR, Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol. 1992;20:1284-1293.
7. den Heijer P, Foley DP, Escaned J, et al. Angioscopic versus angiographic detection of intimai dissection and intracoronary thrombus. J Am Coll Cardiol. 1994;24:649-654.
8. White CJ, Ramee SR, Collins TJ, et al. Coronary thrombi increase PTCA risk: angioscopy as a clinical tool. Circulation. 1996;93:253-258.
9. Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) research group. Effect of long-term anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Lancet. 1994;343:499-503.
10. Cohen M, Adams PC, Parry G, et al. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Circulation. 1994;89:81-88.
11. Rosendaal FR, Cannegieter SC, van der Meer FJM, et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69:236-239.
12. Ernst SMPG, van der Feltz TA, Bal ET, et al. Long term angiographic follow up, cardiac events, and survival in patients undergoing percutaneous transluminal coronary angioplasty. Br Heart J. 1987;57:220-225.
13. Plokker HWM, Ernst SMPG, Bal ET, et al. Percutaneous transluminal coronary angioplasty in patients with unstable angina pectoris refractory to medical therapy: long-term clinical and angiographic results. Cathet Cardiovasc Diagn. 1988;14:15-18.
14. ten Berg JM, Bal ET, Tjon Joe Gin RM, et al. Initial and long-term results of percutaneous transluminal coronary angioplasty in patients 75 years of age and older. Cathet Cardiovasc Diagn. 1992;26:165-170.
15. ten Berg JM, Tjon Joe Gin RM, Ernst SMPG, et al. Ten-year follow-up of percutaneous transluminal coronary angioplasty for proximal left anterior descending coronary artery stenosis in 351 patients. J Am Coll Cardiol. 1996;28:82-88.
16. Thornton MA, Gruentzig AR, Hollman J, et al. coumarins and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study. Circulation. 1984;69:721-727.
17. Urban P, Buller N, Fox K, et al. Lack of effect of warfarin on the restenosis rate or on clinical outcome after balloon coronary angioplasty. Br Heart J. 1988;60:485-488.
18. Schömig A, Neumann F-J, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stems. N Engl J Med. 1996;334:1084-1089.
19. Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med. 1998;339:1665-1671.
20. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489-495.
21. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496-501.